Impact of Biologic Treatment of Ulcerative Colitis on Healthcare Resource Utilization in US Patients

(1) Eli Lilly and Company,Indianapolis,United States



This item was part of the IBD: Health care and patient-reported outcomes session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019